Correlation Between Cytek Biosciences and Design Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cytek Biosciences and Design Therapeutics, you can compare the effects of market volatilities on Cytek Biosciences and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Design Therapeutics.

Diversification Opportunities for Cytek Biosciences and Design Therapeutics

0.35

Correlation Coefficient

Cytek Biosciences  Design Therapeutics

Weak diversification

The 3 months correlation between Cytek and Design is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Design Therapeutics go up and down completely randomly.

Pair Corralation between Cytek Biosciences and Design Therapeutics

Given the investment horizon of 90 days Cytek Biosciences is expected to generate 1.86 times less return on investment than Design Therapeutics. In addition to that, Cytek Biosciences is 1.32 times more volatile than Design Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Design Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest  333.00  in Design Therapeutics on May 7, 2025 and sell it today you would earn a total of  63.00  from holding Design Therapeutics or generate 18.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cytek Biosciences  vs.  Design Therapeutics

Cytek Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward-looking signals, Cytek Biosciences may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Design Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cytek Biosciences and Design Therapeutics

The main advantage of trading using opposite Cytek Biosciences and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.

The idea behind Cytek Biosciences and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.